Narrative review of primary care point-of-care testing (POCT) and antibacterial use in respiratory tract infection (RTI)

Jonathan Cooke (Lead Author), Christopher Butler, Rogier Hopstaken, Matthew Scott Dryden, Cliodna McNulty, Simon Hurding, Michael Moore, David Martin Livermore

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)
4 Downloads (Pure)

Abstract

Antimicrobial resistance is a global problem and is being addressed through national strategies to improve diagnostics, develop new antimicrobials and promote antimicrobial stewardship. A narrative review of the literature was undertaken to ascertain the value of C reactive protein (CRP) and procalcitonin,
measurements to guide antibacterial prescribing in adult patients presenting to GP practices with symptoms of respiratory tract infection (RTI). Studies
that were included were randomised controlled trials,controlled before and after studies, cohort studies and economic evaluations. Many studies demonstrated that the use of CRP tests in patients presenting with RTI symptoms reduces antibiotic prescribing by 23.3% to36.16%. Procalcitonin is not currently available as a point-of-care testing (POCT), but has shown value for patients with RTI admitted to hospital. GPs and patients report a good acceptability for a CRP POCT
and economic evaluations show cost-effectiveness of CRP POCT over existing RTI management in primary care. POCTs increase diagnostic precision for GPs in
the better management of patients with RTI. CRP POCT can better target antibacterial prescribing by GPs and contribute to national antimicrobial resistance strategies. Health services need to develop ways to ensure funding is transferred in order for POCT to be implemented.
Original languageEnglish
Article numbere000086
JournalBMJ Open Respiratory Research
Volume2
Issue number1
DOIs
Publication statusPublished - 6 May 2015

Cite this